無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

陽子線治療の日本市場:癌区分別の患者数・償還政策・治療患者数

Japan Proton Therapy Market, Patients by 10 Cancer Types (CNS, GI, HCC, etc.) Reimbursement Policies & Persons Treated at Centers

発行 Renub Research 商品コード 427205
出版日 ページ情報 英文 105 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.61円で換算しております。
Back to Top
陽子線治療の日本市場:癌区分別の患者数・償還政策・治療患者数 Japan Proton Therapy Market, Patients by 10 Cancer Types (CNS, GI, HCC, etc.) Reimbursement Policies & Persons Treated at Centers
出版日: 2018年03月13日 ページ情報: 英文 105 Pages
概要

日本の陽子線治療の市場は2024年末には80億米ドルを超える規模に成長する可能性を示しています。

当レポートでは、日本の陽子治療の市場を調査し、実際の市場と潜在市場の規模の推移と予測、実際の患者数と潜在的患者数の推移と予測、癌区分別の市場規模・患者数の推移と予測、償還政策、標準的な陽子線治療センターの設備、主要企業の分析、市場成長推進因子・課題の分析などをまとめています。

第1章 エグゼクティブサマリー

第2章 市場の推移と予測

  • 実際の市場
  • 潜在市場

第3章 患者数の推移と予測

  • 実際の患者数
  • 潜在的患者数

第4章 患者数の推移と予測:癌タイプ別

  • 中枢神経系腫瘍
  • 頭頸部癌
  • 肺癌
  • 消化器癌
  • 肝細胞癌
  • 膵癌
  • 婦人科腫瘍
  • 前立腺癌
  • 骨腫瘍・軟部腫瘍
  • その他

第5章 市場の推移と予測:癌タイプ別

  • 中枢神経系腫瘍
  • 頭頸部癌
  • 肺癌
  • 消化器癌
  • 肝細胞癌
  • 膵癌
  • 婦人科腫瘍
  • 前立腺癌
  • 骨腫瘍・軟部腫瘍
  • その他

第6章 陽子治療センターのリスト

  • 運用中
  • 建設中
  • 計画中

第7章 治療中の患者数の推移:センター別

  • 国立がんセンター東病院
  • 兵庫県立粒子線医療センター
  • 筑波大学陽子線医学利用研究センター
  • 若狭湾エネルギー研究センター
  • 静岡県立がんセンター
  • 南東北がん陽子線治療センター
  • メディポリス国際陽子線治療センター
  • 福井県陽子線がん治療センター
  • 名古屋陽子線治療センター
  • 九州国際重粒子線がん治療センター
  • 相澤病院陽子線治療センター
  • 北海道大学病院陽子線治療センター

第8章 償還政策

第9章 標準的な陽子治療センターの設備

  • 陽子加速器
    • シンクロトロン (例:LLUMC at Loma Linda)
    • サイクロトロン (例:MGH Boston)
    • シンクロサイクロトロン (例:Orsay・Uppsala)
    • Hマイナスシンクロトロン
    • セパレートセクターサイクロトロン
    • 超伝導サイクロトロン
    • 高速回転サイクロトロン
  • ビーム輸送系
  • ビームデリバリーシステム
    • 受動散乱体法
    • ビームスキャニング
  • ノズル
    • 単一散乱
    • 多重散乱
    • ユニフォームスキャニング
    • ペンシルスキャニング
  • 治療プランニングシステム
  • 画像ビューアー
  • 患者ポジショニングシステム (PPS)
  • 人的資源

第10章 企業分析

  • IBA Proton Therapy
  • Varian Medical Systems
  • Elekta

第11章 陽子治療:促進因子

  • 技術進歩
  • 日本における癌患者の発生率の増加

第12章 陽子治療:課題

  • 大規模な投資の必要性
  • 運営上の課題
目次

Japan Proton Therapy Market has potential to surpass US$ 8 Billion by the end of year 2024. Japan proton therapy industry is among one of most alluring market in the world. The report contains historical analysis of proton therapy industry, current outlook, market demand and future prospects of the industry along with competitive landscape and mega trends. This report provides Japan proton therapy patient numbers and market in 10 types of cancer. This report covers list of all proton therapy centers in operational state, under-construction and planning phase. Report also provides Japan proton therapy reimbursement policies.

By Cancer Type - Japan Proton Therapy Market & Patient Numbers

In proton therapy, the frequency of patients is much higher in prostate cancer because of its compatibility and survival rate. In this report, we have done in-depth analysis of proton therapy market and proton therapy patient numbers by cancer or tumor type to reveal which cancer type has more or less penetration in proton therapy technology. All 10 types of Cancer proton therapy data captured in the report are as follows: Central Nervous System (CNS) Tumors, Head and Neck Cancer, Prostate Cancer, Lung Cancer, GI (Gastro-Intestinal) Cancer, Hepatocellular Carcinoma (HCC), Pancreas Cancer, Gynecologic Cancers, Bone and Soft Tissue Cancer, Others).

Treated Patients Statistics by Proton Therapy Center in Japan

In this report, we have comprehensively covered the number of proton therapy patients treated by each individual center since their inception and till 2016. According to our analysis, each proton therapy center in Japan is able to manage patients, which is significantly growing over the period of time. Moreover they are also expanding their capacity, improving technical skills and changing minor technology for the treatment of more people simultaneously.

Renub Research report Japan Proton Therapy Market, Patients by 10 Cancer Types (Central Nervous System (CNS), Head and Neck, Lung, GI (Gastro-Intestinal), Hepatocellular Carcinoma (HCC), Pancreas, Gynecologic, Prostate, Bone and Soft Tissue, Others) Reimbursement Policies & Persons Treated at Centers provides a comprehensive assessment of the fast-evolving, high-growth of Proton Therapy Market.

The report studies the Market and Patients numbers, of 10 individual cancer types who are treated under proton therapy. The report also talks about list of all operational and future Proton Therapy centers; Reimbursement Policies. The report also studies the Proton Therapy Revenue of 3 Companies.

Types of Proton Therapy Market (Actual & Untapped)

  • a) Actual Market is the current market which is already present
  • b) Untapped Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year

Japan Proton Therapy Market has been analyzed from six view points

  • 1. Japan Proton Therapy Actual Market
  • 2. Japan Proton Therapy Untapped Market
  • 3. Japan Proton Therapy Treated Patient Numbers
  • 4. Japan Proton Therapy Untapped Patient Numbers
  • 5. By Cancer Type - Japan Proton Therapy Market
  • 6. By Cancer Type - Japan Proton Therapy Number of Patients

10 Types of Cancer Patient Numbers and Market in Japan Proton Therapy

  • 1. Central Nervous System (CNS) Tumors
  • 2. Head and Neck Cancer
  • 3. Prostate Cancer
  • 4. Lung Cancer
  • 5. GI (Gastro-Intestinal) Cancer
  • 6. Hepatocellular Carcinoma (HCC) Cancer
  • 7. Pancreas Cancer
  • 8. Gynecologic Cancers
  • 9. Bone and Soft Tissue Cancer
  • 10. Others Cancer

Key Companies Covered

  • 1. IBA (Overview, Sales Analysis)
  • 2. Varian Medical Systems (Overview, Sales Analysis)
  • 3. Elekta (Overview, Sales Analysis)

Table of Contents

1. Executive Summary

2. Market (Actual & Untapped)-Japan Proton Therapy (2009-2024)

  • 2.1. Actual Proton Therapy Market
  • 2.2. Untapped Proton Therapy Market

3. Number of Patients-Japan Proton Therapy (2009-2024)

  • 3.1. Actual Numbers
  • 3.2. Untapped Numbers

4. Cancer Types-Japan Proton Therapy Number of Patients (2009-2024)

  • 4.1. Central Nervous System (CNS) Tumors
  • 4.2. Head and Neck Cancer
  • 4.3. Lung Cancer
  • 4.4. GI (Gastro-Intestinal) Cancer
  • 4.5. Hepatocellular Carcinoma (HCC) Cancer
  • 4.6. Pancreas Cancer
  • 4.7. Gynecologic Cancers
  • 4.8. Prostate Cancer
  • 4.9. Bone and Soft Tissue Cancer
  • 4.10. Others Cancer

5. Cancer Types-Japan Proton Therapy Market (2009-2024)

  • 5.1. Central Nervous System (CNS) Tumors
  • 5.2. Head and Neck Cancer
  • 5.3. Lung Cancer
  • 5.4. GI (Gastro-Intestinal) Cancer
  • 5.5. Hepatocellular Carcinoma (HCC) Cancer
  • 5.6. Pancreas Cancer
  • 5.7. Gynecologic Cancers
  • 5.8. Prostate Cancer
  • 5.9. Bone and Soft Tissue Cancer
  • 5.10. Others Cancer

6. Japan-List of Proton Therapy Centers

  • 6.1. Operating Proton Therapy Centers
  • 6.2. Under-Construction Therapy Centers
  • 6.3. Planning Proton Therapy Centers

7. By Centers-Number of Proton Therapy Patients Treated

  • 7.1. Kashiwa (NCC) Proton Therapy Center (2008-2016)
  • 7.2. Hyogo (HIBMC) Proton Therapy Center (2008-2016)
  • 7.3. Tsukuba (PMRC, 2) Proton Therapy Center (2008-2016)
  • 7.4. WERC Proton Therapy Center (2008-2009)
  • 7.5. Shizuoka Proton Therapy Center (2008-2016)
  • 7.6. Koriyama-City Proton Therapy Center (2008-2016)
  • 7.7. Ibusuki (MMRI) Proton Therapy Center (2011-2016)
  • 7.8. Fukui City (Prefectural Hospital) Proton Therapy Center (2013-2015)
  • 7.9. Nagoya PTC, Nagoya, Aichi Proton Therapy Center (2013-2016)
  • 7.10. Tosu (Saga-HIMAT) Proton Therapy Center (2013)
  • 7.11. Nagano Proton Therapy Center (2014-2016)
  • 7.12. Hokkaido Proton Therapy Center (2014-2016)

8. Reimbursement Policies-Japan Proton Therapy

9. Components of a Standard Proton Therapy Center

  • 9.1. Type of Proton Accelerator
    • 9.1.1. Synchrotrons (example: LLUMC at Loma Linda)
    • 9.1.2. Cyclotrons (example: MGH Boston)
    • 9.1.3. Synchrocyclotrons (examples: Orsay, Uppsala)
    • 9.1.4. Linacs (Rome)
    • 9.1.5. H-minus Synchrotrons
    • 9.1.6. Separated Sector Cyclotrons
    • 9.1.7. Super-conducting Cyclotrons
    • 9.1.8. Fast Cycling Synchrotron
  • 9.2. Beam Transport System
  • 9.3. Beam Delivery System
    • 9.3.1. The Passive Scattering Technique
    • 9.3.2. Beam Scanning
  • 9.4. Type of Nozzle
    • 9.4.1. Single Scattering
    • 9.4.2. Double Scattering
    • 9.4.3. Uniform Scanning Nozzle
    • 9.4.4. Pencil Scanning Nozzle
  • 9.5. Treatment Planning System
  • 9.6. Image Viewers
  • 9.7. Patient Positioning System (PPS)
  • 9.8. Human Resource

10. Company Analysis (2010-2024)

  • 10.1. IBA Proton Therapy
    • 10.1.1. Sales Analysis
  • 10.2. Varian Medical Systems
    • 10.2.1. Sales Analysis
  • 10.3. Elekta
    • 10.3.1. Sales Analysis

11. Proton Therapy-Driving Factors

  • 11.1. Technology Advancement
    • 11.1.1. Next-Generation Proton Technique
  • 11.2. Growing Incidence of Cancer Patients in Japan

12. Challenges

  • 12.1. Requires Huge Investment
  • 12.2. Operation Challenges

List of Figures

  • Figure 2 1: Japan - Proton Therapy Market (Million US$), 2009 - 2017
  • Figure 2 2: Japan - Forecast for Proton Therapy Market (Million US$), 2018 - 2024
  • Figure 2 3: Japan - Untapped Proton Therapy Market (Million US$), 2009 - 2017
  • Figure 2 4: Japan - Forecast for Untapped Proton Therapy Market (Million US$), 2018 - 2024
  • Figure 3 1: Japan - Patient Treated with Proton Therapy (Number), 2009 - 2017
  • Figure 3 2: Japan - Forecast for Patient Treated with Proton Therapy (Number), 2018 - 2024
  • Figure 3 3: Japan - Untapped Patients for Proton Therapy (Number), 2009 - 2016
  • Figure 3 4: Japan - Forecast for Untapped Patients for Proton Therapy (Number), 2017 - 2021
  • Figure 4 1: Japan - Proton Therapy Patients by CNS (Number), 2009 - 2017
  • Figure 4 2: Japan - Forecast for Proton Therapy Patients by CNS (Number), 2018 - 2024
  • Figure 4 3: Japan - Proton Therapy Patients by Head and Neck (Number), 2009 - 2017
  • Figure 4 4: Japan - Forecast for Proton Therapy Patients by Head and Neck (Number), 2018 - 2024
  • Figure 4 5: Japan - Proton Therapy Patients by Lung Cancer (Number), 2009 - 2017
  • Figure 4 6: Japan - Forecast for Proton Therapy Patients by Lung Cancer (Number), 2018 - 2024
  • Figure 4 7: Japan - Proton Therapy Patients by GI Cancer (Number), 2009 - 2017
  • Figure 4 8: Japan - Forecast for Proton Therapy Patients by GI Cancer (Number), 2018 - 2024
  • Figure 4 9: Japan - Proton Therapy Patients by HCC (Number), 2009 - 2017
  • Figure 4 10: Japan - Forecast for Proton Therapy Patients by HCC (Number), 2018 - 2024
  • Figure 4 11: Japan - Proton Therapy Patients by Pancreas (Number), 2009 - 2017
  • Figure 4 12: Japan - Forecast for Proton Therapy Patients by Pancreas (Number), 2018 - 2024
  • Figure 4 13: Japan - Proton Therapy Patients by Gynecologic Cancer (Number), 2009 - 2017
  • Figure 4 14: Japan - Forecast for Proton Therapy Patients by Gynecologic Cancer (Number), 2018 - 2024
  • Figure 4 15: Japan - Proton Therapy Patients by Prostate Cancer (Number), 2009 - 2017
  • Figure 4 16: Japan - Forecast for Proton Therapy Patients by Prostate Cancer (Number), 2018 - 2024
  • Figure 4 17: Japan - Proton Therapy Patients by Bone and Soft Tissue (Number), 2009 - 2017
  • Figure 4 18: Japan - Forecast for Proton Therapy Patients by Bone and Soft Tissue (Number), 2018 - 2024
  • Figure 4 19: Japan - Proton Therapy Patients by Others (Number), 2009 - 2017
  • Figure 4 20: Japan - Forecast for Proton Therapy Patients by Others (Number), 2018 - 2024
  • Figure 5 1: Japan - Proton Therapy Market by CNS (Million US$), 2009 - 2017
  • Figure 5 2: Japan - Forecast for Proton Therapy Market by CNS (Million US$), 2018 - 2024
  • Figure 5 3: Japan - Proton Therapy Market by Head and Neck Cancer (Million US$), 2009 - 2017
  • Figure 5 4: Japan - Forecast for Proton Therapy Market by Head and Neck Cancer (Million US$), 2018 - 2024
  • Figure 5 5: Japan - Proton Therapy Market by Lung Cancer (Million US$), 2009 - 2017
  • Figure 5 6: Japan - Forecast for Proton Therapy Market by Lung Cancer (Million US$), 2018 - 2024
  • Figure 5 7: Japan - Proton Therapy Market by GI Cancer (Million US$), 2009 - 2017
  • Figure 5 8: Japan - Forecast for Proton Therapy Market by GI Cancer (Million US$), 2018 - 2024
  • Figure 5 9: Japan - Proton Therapy Market by HCC (Million US$), 2009 - 2017
  • Figure 5 10: Japan - Forecast for Proton Therapy Market by HCC (Million US$), 2018 - 2024
  • Figure 5 11: Japan - Proton Therapy Market by Pancreas (Million US$), 2009 - 2017
  • Figure 5 12: Japan - Forecast for Proton Therapy Market by Pancreas (Million US$), 2018 - 2024
  • Figure 5 13: Japan - Proton Therapy Market by Gynecologic cancers (Million US$), 2009 - 2017
  • Figure 5 14: Japan - Forecast for Proton Therapy Market by Gynecologic cancers (Million US$), 2018 - 2024
  • Figure 5 15: Japan - Proton Therapy Market by Prostate cancers (Million US$), 2009 - 2017
  • Figure 5 16: Japan - Forecast for Proton Therapy Market by Prostate cancers (Million US$), 2018 - 2024
  • Figure 5 17: Japan - Proton Therapy Market by Bone and Soft Tissue (Million US$), 2009 - 2017
  • Figure 5 18: Japan - Forecast for Proton Therapy Market by Bone and Soft Tissue (Million US$), 2018 - 2024
  • Figure 5 19: Japan - Proton Therapy Market by Others (Million US$), 2009 - 2017
  • Figure 5 20: Japan - Forecast for Proton Therapy Market by Others (Million US$), 2018 - 2024
  • Figure 10 1: Global - IBA Proton Therapy Sales (Million US$), 2010 - 2017
  • Figure 10 2: Global - Forecast for IBA Proton Therapy Sales (Million US$), 2018 - 2024
  • Figure 10 3: Global - Varian Medical Systems Oncology Systems Sales (Million US$), 2010 - 2017
  • Figure 10 4: Global - Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2018 - 2024
  • Figure 10 5: Global - Elekta Radiation Technology Sales (Million US$), 2010 - 2017
  • Figure 10 6: Global - Forecast for Elekta Radiation Technology Sales (Million US$), 2018 - 2024
  • Figure 11 1: Japan - Number of Patient Diagnosed With Cancer (Thousand), 2009 - 2017
  • Figure 11 2: Japan - Forecast for Number of Patient Diagnosed With Cancer (Thousand), 2018 - 2024

List of Tables

  • Table 6 1: Japan - Proton Therapy Centers in Operation
  • Table 6 2: Japan - Proton Therapy Centers in Under-Construction
  • Table 6 3: Japan - Proton Therapy Centers in Planning Phase
  • Table 7 1: Japan - Kashiwa (NCC) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7 2: Japan - Hyogo (HIBMC) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7 3: Japan - Tsukuba (PMRC, 2) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7 4: Japan - WERC Proton Therapy Center with Patients Treated (Number), 2008 - 2009
  • Table 7 5: Japan - Shizuoka Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7 6: Japan - Koriyama-City Proton Therapy Center with Patients Treated (Number), 2011 - 2016
  • Table 7 7: Japan - Ibusuki (MMRI) Proton Therapy Center with Patients Treated (Number), 2011 - 2016
  • Table 7 8: Japan - Fukui City (Prefectural Hospital) Proton Therapy Center with Patients Treated (Number), 2013 - 2015
  • Table 7 9: Japan - Nagoya PTC, Nagoya, Aichi Proton Therapy Center with Patients Treated (Number), 2013 - 2016
  • Table 7 10: Japan - Tosu (Saga-HIMAT) Proton Therapy Center with Patients Treated (Number), 2013
  • Table 7 11: Japan - Nagano Proton Therapy Center with Patients Treated (Number), 2014 - 2016
Back to Top